C Ricordi - Diabetes, 2003 - medscape.com It has indeed been a distinct honor to be the recipient of the 2002 Outstanding Scientific Achievement
Award, and I was happy to accept it, on behalf of the entire islet transplant field, as there have
been many surgeons, physicians, and scientists who have worked as a team, moving this ... Cited by 100 - Related articles - All 8 versions
- ►ualberta.ca [PDF] AN Balamurugan, R Bottino, N Giannoukakis, C … - Pancreas, 2006 - journals.lww.com Abstract: Pancreatic islet cell transplantation is an attractive treatment of type 1 diabetes
(T1D). The success enhanced by the Edmonton protocol has fostered phenomenal progress
in the field of clinical islet transplantation in the past 5 years, with 1-year rates of insulin ... Cited by 31 - Related articles - BL Direct - All 4 versions
T Berney, A Pileggi, RD Molano, R Poggioli, E Zahr, … - Transplantation, 2003 - journals.lww.com Skip Navigation Links Home > December 27, 2003 - Volume 76 - Issue 12 > The effect of simultaneous
CD154 and LFA-1 blockade on the s... ... 2 Cell Transplant Center, Diabetes Research
Institute, University of Miami School of Medicine, Miami, FL. ... 3 Cell Transplant Center, ... Cited by 29 - Related articles - BL Direct - All 4 versions
A Pileggi, C Ricordi, NS Kenyon, T Froud, DA Baidal, … - Transplantation - diabetesresearch.org Intensive insulin therapy with the goal of maintain- ing blood glucose concentrations close to
the normal range can delay or prevent the onset of diabetes compli- cations in patients with type
1 diabetes mellitus (T1DM)(1). This goal is difficult to achieve in the major- ity of patients ... Cited by 24 - Related articles - View as HTML - BL Direct - All 2 versions
LM Howard, AP Kohm, CL Castaneda, … - Current Drug Targets- …, 2005 - ingentaconnect.com # Departments of Microbiology-Immunology and the Interdepartmental Immunobiology
Center, Northwestern University Medical School, Chicago, IL 60611, USA ^Department of
Biology, Indiana University Northwest, Gary, IN 46408, USA Abstract: Autoimmune ... Cited by 18 - Related articles - All 2 versions
- ►endojournals.org H Wang, SS Lee, C Dell'Agnello, V Tchipashvili, J D' … - Endocrinology, 2006 - Endocrine Soc Induction of heme oxygenase-1 (HO-1) expression in recipients of allogeneic islets can lead
to long-term survival (>100 d) of those islets. We tested whether administration of bilirubin would
substitute for the beneficial effects of HO-1 expression in islet transplantation. ... Cited by 19 - Related articles - BL Direct - All 5 versions
LM Howard, SD Miller - Autoimmunity, 2004 - informahealthcare.com The CD154–CD40 ligand pair interaction plays a central role in both induction of the immune
response and in immune effector functions. Indeed, many animal disease models and human
autoimmune diseases have demonstrated a central role for CD154 expression. The ... Cited by 18 - Related articles - All 6 versions
- ►fasebj.org SS Lee, W Gao, S Mazzola, MN Thomas, E Csizmadia, … - The FASEB Journal, 2007 - FASEB Heme oxygenase-1 (HO-1) induction in, or carbon monoxide (CO), or bilirubin administration
to, donors and/or recipients frequently lead to long-term survival (>100 days) of DBA/2 islets
into B6AF1 recipients. We tested here whether similar treatments show value in a ... Cited by 17 - Related articles - BL Direct - All 4 versions
T Pearson, P Weiser, TG Markees, DV Serreze, LS … - Diabetes, 2004 - Am Diabetes Assoc NOD mice develop type 1 autoimmune diabetes and exhibit genetically dominant resistance
to transplantation tolerance induction. These two phenotypes are genetically separable. Costimulation
blockade fails to prolong skin allograft survival in (NOD × C57BL/6)F1 mice and in NOD- ... Cited by 16 - Related articles - BL Direct - All 6 versions
